Fax: (773) 795-7398
Article first published online: 20 JUL 2011
Copyright © 2011 American Cancer Society
Supplement: National Patient Navigation Leadership Summit (NPNLS): Measuring the Impact and Potential of Patient Navigation, Supplement to Cancer
Volume 117, Issue Supplement 15, pages 3616–3623, 1 August 2011
How to Cite
Whitley, E., Valverde, P., Wells, K., Williams, L., Teschner, T. and Shih, Y.-C. T. (2011), Establishing common cost measures to evaluate the economic value of patient navigation programs. Cancer, 117: 3616–3623. doi: 10.1002/cncr.26268
The articles in this supplement are based on presentations at the “National Patient Navigator Leadership Summit”; March 23-24, 2010; Atlanta, GA.
The opinions or views expressed in this supplement are those of the authors, and do not necessarily reflect the opinions or recommendations of the publisher, the editors, the University of Illinois at Chicago, the American Cancer Society, or the Ralph Lauren Center for Cancer Care and Prevention.
National Patient Navigator Leadership Summit (NPNLS): Measuring the Impact and Potential of Patient Navigation, Supplement to Cancer.
- Issue published online: 20 JUL 2011
- Article first published online: 20 JUL 2011
- Manuscript Accepted: 6 MAY 2011
- Manuscript Revised: 2 MAY 2011
- Manuscript Received: 24 FEB 2011
- patient navigation;
- economic evaluation
Patient navigation is an intervention aimed at reducing barriers to health care for underserved populations as a means to reduce cancer health disparities. Despite the proliferation of patient navigation programs across the United States, information related to the economic impact and sustainability of these programs is lacking.
After a review of the relevant literature, the Health Services Research (HSR)-Cost workgroup of the American Cancer Society National Patient Navigator Leadership Summit met to examine cost data relevant to assessing the economic impact of patient navigation and to propose common cost metrics.
Recognizing that resources available for data collection, management, and analysis vary, 5 categories of core and optional cost measures were identified related to patient navigator programs, including program costs, human capital costs, direct medical costs, direct non-medical costs, and indirect costs.
Information demonstrating economic as well as clinical value is necessary to make decisions about sustainability of patient navigation programs. Adoption of these common cost metrics are recommended to promote understanding of the economic impact of patient navigation and comparability across diverse patient navigation programs. Cancer 2011;117(15 suppl):3616–623. © 2011 American Cancer Society.